en

PRODUCT DETAIL

ZAHRON COMBI 20 mg/5 mg

Code 7417C
MA number 58/0112/18-S
Product Form: cps dur 56x20 mg/5 mg (blis.PA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BX HMG CoA reductase inhibitors, other combinations
C10BX09 Rosuvastatine and amlodipine
Shelf life: 30
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 23.03.2018
Validity: 23.03.2023
MA renewed: Renewal application submitted
PIL: PIL_ZAHRON COMBI_cps dur_09/2022.pdf  
SPC: SPC_ZAHRON COMBI_cps dur_09_2022.pdf  
Safety feature Yes
Data update: 11.07.2018
eu-flag.png sk-flag.png